U.S. Telecom Services and Carriers Stock News

NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

A Look At Palantir Technologies (PLTR) Valuation After AIPCon 10 And Raised Guidance

Palantir Technologies (PLTR) is back in focus after reporting 85% year over year revenue growth, raising full year guidance, and using AIPCon 10 to showcase deeper adoption of its AI platforms. See our latest analysis for Palantir Technologies. Despite the strong AIPCon 10 news flow and raised guidance, Palantir’s share price is down 18.7% year to date, with a 7 day share price return of a 15.05% decline. The 3 year total shareholder return is around 7x, suggesting long term momentum remains...
NasdaqCM:ABAT
NasdaqCM:ABATMetals and Mining

American Battery Technology (ABAT) Is Up 6.1% After DOE Reinstates US$115M Grant For Lithium Refinery

American Battery Technology Company recently won its appeal with the U.S. Department of Energy, securing full reinstatement of a US$115 million grant to fund the first phase of its Tonopah Flats Lithium Project refinery, with all technical and commercial milestones preserved and the schedule adjusted for the review-related delay. This decision follows multi-administration federal backing and a Pre-Feasibility Study outlining a long-life lithium project, highlighting sustained government...
NYSE:VFC
NYSE:VFCLuxury

Assessing V.F (VFC) Valuation After Recent Share Price Weakness And Turnaround Hopes

Recent performance snapshot V.F (VFC) has drawn investor attention after a mixed stretch for the stock, with the price at $16.62 and returns down 12% over the past month and about 2% over the past 3 months. See our latest analysis for V.F. Looking beyond the recent pullback, V.F's 1 year total shareholder return of 30.63% contrasts with a softer year to date share price return of an 8.48% decline. This suggests momentum has faded and recent moves may reflect changing views on future growth...
NYSE:GPK
NYSE:GPKPackaging

A Look At Graphic Packaging Holding (GPK) Valuation After Recent Share Price Weakness

Why Graphic Packaging Holding (GPK) Is Drawing Investor Attention Graphic Packaging Holding (GPK) is back on investor radars after recent trading left the stock around $10.52, with returns down over the past year but slightly positive in the past 3 months. See our latest analysis for Graphic Packaging Holding. Recent trading has been choppy, with the latest 7 day share price return down 6.16% and the year to date share price return down 30.56%. The 1 year total shareholder return has declined...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Assessing Veracyte (VCYT) Valuation After New Prosigna Launch And Decipher Prostate Clinical Milestones

Veracyte (VCYT) is in focus after a busy period of clinical milestones, led by the U.S. commercial launch of its Prosigna Breast Risk of Recurrence test and new Phase III data across breast and prostate cancer. See our latest analysis for Veracyte. Despite a small pullback in the latest session, with the 1 day share price return down 3%, Veracyte’s 30 day share price return of 16.95% and 90 day share price return of 44.2% sit alongside a 1 year total shareholder return of 69.73%. This...
NasdaqGS:XERS
NasdaqGS:XERSPharmaceuticals

Should Xeris Biopharma’s Q1 Beat and Director Stock Moves Prompt a Fresh Look From XERS Investors?

In early June 2026, Xeris Biopharma director Marla Persky sold 15,500 shares under a Rule 10b5-1 plan, then received new restricted stock units and stock options as part of the company’s 2018 Stock Option and Incentive Plan. Around the same time, Xeris Biopharma reported a 38% year-on-year increase in Q1 2026 revenue and earnings per share above market expectations, underscoring stronger-than-anticipated operating momentum. Now we’ll examine how Xeris’s better-than-expected Q1 revenue...
NasdaqGM:AIP
NasdaqGM:AIPSoftware

Is Arteris (AIP) Overvalued After Its Powerful One Year Share Price Run

Arteris stock performance snapshot Arteris (AIP) has drawn investor attention recently as its stock shows mixed short term moves, with a gain over the past month contrasted by a decline over the past week. See our latest analysis for Arteris. That short term pullback sits against a much stronger backdrop, with a 30 day share price return of 10.67%, a 90 day share price return of 131.21%, and a very large 1 year total shareholder return of 340.20%. Taken together, these figures suggest...
NYSE:OMF
NYSE:OMFConsumer Finance

Assessing OneMain Holdings (OMF) Valuation As Legal Risks And Insider Selling Shape Investor Attention

Why OneMain Holdings Is Back in Focus OneMain Holdings (OMF) is back on investor radars after perceived undervaluation met a cluster of risk signals, including weak financial strength scores, insider selling, legal overhang, and pressure in nonprime lending. See our latest analysis for OneMain Holdings. Recent price moves show this tension clearly. The share price is down 3.6% over the past month and down 21.7% year to date. However, 1 year and 3 year total shareholder returns of 10.1% and...
NasdaqGS:HST
NasdaqGS:HSTHotel and Resort REITs

A Look At Host Hotels & Resorts (HST) Valuation After Sector Rotation And Supportive Macro Tailwinds

Stock move tied to sector rotation and macro tailwinds Host Hotels & Resorts (HST) stock moved as investors shifted money from technology stocks into real estate investment trusts, supported by a strong U.S. jobs report and declining mortgage rates that aided sentiment toward commercial real estate. See our latest analysis for Host Hotels & Resorts. At a share price of $24.44, HST has seen momentum build, with a 30-day share price return of 9.74%, a 90-day share price return of 26.96% and a...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

Assessing CareDx (CDNA) Valuation After Recent Share Price Volatility And Rebuilding Momentum

How CareDx stock has been performing CareDx (CDNA) has traded around $21.95 recently, with mixed short term returns and stronger performance over the past 3 years, creating an interesting backdrop for investors assessing risk and potential reward. See our latest analysis for CareDx. Recent trading has been choppy, with the share price down 1.35% over the last day and 3.73% over the past week. Despite this, the stock is still showing a 29.27% 90 day share price return and a 164.46% 3 year...
NYSE:DY
NYSE:DYConstruction

A Look At Dycom Industries (DY) Valuation After Strong Q1 Results And Raised 2027 Guidance

Dycom Industries (DY) stock has been in focus after the company reported first quarter revenue of US$1,964.78 million and net income of US$91.29 million, along with higher full year fiscal 2027 revenue guidance. See our latest analysis for Dycom Industries. Despite a dip of about 1.6% in the 1 day share price return and a 7 day share price return down roughly 7.1%, Dycom’s 30 day and 90 day share price returns of 7.1% and 26.4%, alongside a 1 year total shareholder return of 92.6%, point to...
NYSE:PR
NYSE:PROil and Gas

Assessing Permian Resources (PR) Valuation After Earnings Beat And Capital Allocation Update

Why Permian Resources Stock Is Back in Focus Permian Resources (PR) moved back onto investor radar after reporting first quarter 2026 adjusted earnings of $0.39 per share, which topped estimates. The results were supported by stronger production, efficiency gains, and a dividend-centered capital plan that was reaffirmed. See our latest analysis for Permian Resources. Those results arrive while the stock trades at $19.59, with a 36.04% year to date share price return and a 48.06% one year...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Why Semtech (SMTC) Is Up 6.2% After Earnings Beat And Stronger Q2 Sales Outlook

In late May 2026, Semtech Corporation reported first-quarter fiscal 2027 results showing sales of US$291 million and net income of US$26.6 million, with both basic and diluted earnings per share from continuing operations increasing year on year. Alongside this, Semtech issued second-quarter guidance for net sales of about US$328 million, highlighting management’s confidence following stronger-than-expected revenue growth and improved inventory levels. With Semtech’s earnings beating analyst...
NYSE:CLVT
NYSE:CLVTProfessional Services

Is Clarivate (CLVT) Quietly Recasting Its AI IP Strategy With Simon Webster’s Appointment?

Clarivate Plc has appointed Simon Webster as President of its Intellectual Property segment, effective 10 June 2026, succeeding Maroun S. Mourad, who will stay on as a non-executive advisor until 30 September to support the leadership handover. Webster’s prior role as CEO of CPA Global, which Clarivate acquired in 2020, gives him direct experience with the company’s IP assets and could influence how Clarivate develops AI-enabled platforms such as the recently announced IPOne. Next, we’ll...
NYSE:PH
NYSE:PHMachinery

Parker-Hannifin (PH) Valuation Check After Mixed Earnings And Revenue Beat

Parker-Hannifin (PH) just released quarterly results with revenue up 10.6% year on year, topping analyst expectations by 1.6%. However, adjusted operating income came in below estimates, giving investors mixed signals to assess. See our latest analysis for Parker-Hannifin. Parker-Hannifin’s mixed earnings reaction comes after a 7-day share price return of 7.27%, following a period where the share price fell 7.08% over 90 days, while the 1-year total shareholder return of 32.98% points to...
NYSE:TNET
NYSE:TNETProfessional Services

Assessing TriNet Group (TNET) Valuation After Mixed Short And Long Term Share Price Returns

What recent returns say about TriNet Group stock TriNet Group (TNET) has drawn attention after a mixed run in its stock performance, with the price at $46.75 and returns that differ sharply over the past year and past 3 years. Over the past month the stock gained about 9%, while the past 3 months show an increase of roughly 29%. In contrast, the year to date return is down about 18%, and the 1 year total return is down about 42%. Looking further back, the 3 year total return is down about 53%...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

NVIDIA And Two Quiet AI Beneficiaries Of The OpenAI IPO

OpenAI’s confidential IPO filing, at a reported $852b valuation and paired with an employee share tender, is sharpening attention on listed companies tied to AI. You do not need to chase private deals to have exposure to this theme. Public markets already offer large, established stocks that touch AI infrastructure, tools, or adoption in different ways. This article highlights 3 stocks from our AI Trend screener that appear positively exposed to the OpenAI news and the broader rush of AI...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Is BBB Foods’ US$432 Million Equity Raise Reshaping the Expansion Investment Case for TBBB?

In late May 2026, BBB Foods Inc. completed a US$432.39 million follow-on equity offering of 13,304,174 Class A common shares at US$32.50 per share, following a shelf registration filed for the same security. This capital raise, executed at a modest discount, reinforces BBB Foods’ capacity to fund its hard discount expansion in Mexico while broadening its public float. With the follow-on offering now complete, we’ll examine how this fresh equity capital shapes BBB Foods’ expansion-focused...
NYSE:CBL
NYSE:CBLRetail REITs

CBL’s Harford Mall Sale and Hamilton Place Refi Might Change The Case For Investing In CBL (CBL)

CBL Properties has recently advanced its mixed-use redevelopment plans by selling a 10.47-acre former Macy’s parcel at Harford Mall and has also closed a US$71.9 million non-recourse refinancing of Hamilton Place in Chattanooga. At the same time, CBL is reshaping its tenant mix by bringing in brands such as The Cheesecake Factory, POP MART, Levi’s, and Urban Outfitters to West County Center while existing tenants renovate their stores, highlighting intensive active management of key...
NYSE:LMND
NYSE:LMNDInsurance

Can Lemonade’s Indiana Tesla Discount Reveal the Real Scale of Its AI Edge (LMND)?

Lemonade, Inc. recently expanded its Autonomous Car insurance to Indiana, offering Tesla owners 50% off miles driven using Full Self-Driving (Supervised) and additional savings when bundling with Lemonade renters, pet, or home policies. This move highlights Lemonade’s push to use AI-driven pricing and product design in the auto segment, while still running its broader digital car insurance offering across multiple US states. We’ll now examine how this Indiana launch of discounted Autonomous...
NYSE:UHS
NYSE:UHSHealthcare

How UHS’s Dividend Affirmation and Behavioral Health Push Shape Universal Health Services (UHS) Investors

Universal Health Services, Inc. recently confirmed a US$0.20 per-share cash dividend payable on June 18, 2026, to shareholders of record on June 8, 2026, and participated in the Goldman Sachs 47th Annual Global Healthcare Conference at The Loews Miami Beach Hotel. Alongside solid operating momentum and the Talkspace acquisition, the dividend affirmation underscores management’s confidence in balancing shareholder returns with continued investment in behavioral health expansion. Next, we will...
NYSE:NOG
NYSE:NOGOil and Gas

A Look At Northern Oil And Gas (NOG) Valuation As 2026 Production Guidance Rises

Northern Oil and Gas (NOG) has raised its 2026 production guidance, projecting 143,000 to 148,000 Boe per day, along with higher oil output and more wells turned in line, a shift that could matter for investors. See our latest analysis for Northern Oil and Gas. That higher 2026 production guidance lands at a time when Northern Oil and Gas’s share price has eased back, with the 90 day share price return down 21.87% and the 1 year total shareholder return down 22.82%, even though the 5 year...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

Assessing CleanSpark (CLSK) Valuation After May Bitcoin Production Update

Operating update and what it means for CleanSpark stock CleanSpark (CLSK) released unaudited May bitcoin production figures, reporting 671 bitcoin mined, with a peak single day output of 23.16 and average daily production of 21.66. This provides investors with fresh data on current operations. See our latest analysis for CleanSpark. The stock has been volatile around these updates, with a 1-day share price return of 5.97% and a 7-day share price return down 12.17%. The 90-day share price...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Assessing Zai Lab (ZLAB) Valuation After China Approval Of TIVDAK For Advanced Cervical Cancer

Zai Lab (ZLAB) stock is back in focus after China’s National Medical Products Administration approved TIVDAK for recurrent or metastatic cervical cancer, following positive Phase 3 data and prior approvals in the US, EU, Japan, and other regions. See our latest analysis for Zai Lab. Despite the TIVDAK approval, Zai Lab’s share price has been under pressure, with a 30 day share price return down 11.4% and a 1 year total shareholder return down 56.5%, pointing to weak momentum even as new...